July 17, 2018
Novel Imaging Tracer May Have Promise in Alzheimer's PET scans targeting SV2A assess synaptic density, small study suggests
Positron Emission Tomography (PET) scanning with the compound 11C-UCB-J may provide a direct measure of synaptic density and may be a novel in vivo biomarker for Alzheimer’s and outcome measure for drug trials, reported Ming-Kai Chen, MD, of Yale University in New Haven, Conn., and colleagues in JAMA Neurology. {read more here}